Concepedia

Xianqiong Liu

XL

Statistics

Publications

15

Citations

671

H-Index

14

Active since

2017

Affiliations

Hubei University of Chinese Medicine(Current)

University of California, San Francisco

Universität Greifswald

University of Regensburg

Second Affiliated Hospital of Jilin University

Xianqiong Liu is an author at Hubei University of Chinese Medicine specializing in pharmacology, molecular oncology, and oncology.

Publications per year

2017–2023

15

Publications

15

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis

Haichuan Wang, Shanshan Zhang, Yi Zhang et al. · Journal of Hepatology · 2021 · 95 citations · Full text

, , +12

Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma

Xinhua Song, Xianqiong Liu, Haichuan Wang et al. · Clinical Cancer Research · 2018 · 84 citations · Full text

, , +17

Deep-Fried Atractylodis Rhizoma Protects against Spleen Deficiency-Induced Diarrhea through Regulating Intestinal Inflammatory Response and Gut Microbiota

Kun Shi, Linghang Qu, Xiong Lin et al. · International Journal of Molecular Sciences · 2019 · 76 citations · Full text

, , +17

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis

Haichuan Wang, Jingxiao Wang, Shanshan Zhang et al. · Cellular and Molecular Gastroenterology and Hepatology · 2020 · 75 citations · Full text

, , +17

Pinellia pedatisecta lectin exerts a proinflammatory activity correlated with ROS-MAPKs/NF-κB pathways and the NLRP3 inflammasome in RAW264.7 cells accompanied by cell pyroptosis

Wei Wang, Shanhu Mao, Hongli Yu et al. · International Immunopharmacology · 2018 · 44 citations

, , +13

1–5 of 15